# Elanco Animal Health (ELAN) — Earnings

ELAN · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/elan/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.34 |
| EPS estimate | $0.27 |
| EPS surprise | +26.30% |
| Revenue surprise | +4.23% |
| Revenue | $1.4B |
| Revenue estimate | $1.3B |
| Reported | Aug 5, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1739104/000173910426000043/elan-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/41e5727d-93bf-bdcf-ac52-a6c153ce011b.html) |

Elanco reported Q2 2026 results on August 5, 2026. Earnings per share came in at $0.34, ahead of the $0.27 estimate by 26.30%. Revenue was $1.4 billion against a $1.3 billion consensus, a 4.23% revenue surprise. Compared with Q2 2025, EPS rose about 31% from $0.26 and revenue rose from $1.2 billion.

Annual EPS in the table was $1.11 in 2022, $0.89 in 2023, $0.91 in 2024 and $0.95 in 2025. The first half of 2026 adds up to $0.74, about 17.5% more than the $0.63 of the first half of 2025. Quarterly revenue stayed between about $1.0 billion and $1.2 billion through 2025, then reached $1.4 billion in both 2026 quarters. Second-half EPS trailed the first half in every full year shown. The quarterly high in the table is $0.45 in Q1 2023 and the low is $0.08 in Q4 2023. Elanco beat the EPS estimate in 18 of the last 20 quarters; the misses were Q4 2023 and Q4 2024.

Elanco reported its Q3 results between November 5 and November 8 in each year from 2021 to 2025. That points to early November 2026 for the next report, which will compare with Q3 2025 EPS of $0.19.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 5, 2026 | $0.27 | $0.34 | 26.30% | $1.3B | $1.4B |
| Q1 2026 | May 6, 2026 | $0.35 | $0.40 | 15.74% | $1.3B | $1.4B |
| Q4 2025 | Feb 24, 2026 | $0.11 | $0.13 | 14.54% | $1.1B | $1.1B |
| Q3 2025 | Nov 5, 2025 | $0.13 | $0.19 | 46.15% | $1.1B | $1.1B |
| Q2 2025 | Aug 7, 2025 | $0.20 | $0.26 | 30.85% | $1.2B | $1.2B |
| Q1 2025 | May 7, 2025 | $0.31 | $0.37 | 20.80% | $1.2B | $1.2B |
| Q4 2024 | Feb 25, 2025 | $0.15 | $0.14 | -6.04% | $1.0B | $1.0B |
| Q3 2024 | Nov 7, 2024 | $0.12 | $0.13 | 6.21% | $1.0B | $1.0B |
| Q2 2024 | Aug 8, 2024 | $0.24 | $0.30 | 25.16% | $1.1B | $1.2B |
| Q1 2024 | May 8, 2024 | $0.27 | $0.34 | 24.09% | $1.2B | $1.2B |
| Q4 2023 | Feb 26, 2024 | $0.10 | $0.08 | -23.44% | $1.0B | $1.0B |
| Q3 2023 | Nov 7, 2023 | $0.12 | $0.18 | 44.46% | $1.0B | $1.1B |
| Q2 2023 | Aug 7, 2023 | $0.05 | $0.18 | 282.17% | $1.0B | $1.1B |
| Q1 2023 | May 9, 2023 | $0.29 | $0.45 | 57.89% | $1.2B | $1.3B |
| Q4 2022 | Feb 21, 2023 | $0.13 | $0.19 | 49.14% | $980.9M | $988.0M |
| Q3 2022 | Nov 8, 2022 | $0.16 | $0.20 | 26.10% | $1.0B | $1.0B |
| Q2 2022 | Aug 8, 2022 | $0.25 | $0.36 | 42.74% | $1.2B | $1.2B |
| Q1 2022 | May 9, 2022 | $0.35 | $0.36 | 1.93% | $1.2B | $1.2B |
| Q4 2021 | Feb 24, 2022 | $0.17 | $0.20 | 18.76% | $1.1B | $1.1B |
| Q3 2021 | Nov 5, 2021 | $0.17 | $0.19 | 14.94% | $1.1B | $1.1B |

## Frequently Asked Questions

### When did Elanco Animal Health (ELAN) last report earnings?

Elanco Animal Health last reported on Aug 5, 2026, covering fiscal Q2 2026.

### Did ELAN beat earnings estimates?

Yes. Elanco Animal Health reported EPS of $0.34 for Q2 2026 against a $0.27 estimate — a 26.30% beat.

### How much revenue did ELAN report last quarter?

Elanco Animal Health reported $1.4B in revenue for Q2 2026, against a consensus estimate of $1.3B.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).